IRIS - Res&Arch Institutional Research Information System - Research & Archive

CALABRESI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.699
EU - Europa 9.400
AS - Asia 1.864
Continente sconosciuto - Info sul continente non disponibili 23
SA - Sud America 7
OC - Oceania 6
AF - Africa 4
Totale 22.003
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.669
UA - Ucraina 2.275
IE - Irlanda 2.105
IT - Italia 1.380
SE - Svezia 1.328
HK - Hong Kong 706
VN - Vietnam 649
FI - Finlandia 487
DE - Germania 461
RU - Federazione Russa 423
FR - Francia 387
CN - Cina 307
GB - Regno Unito 222
CH - Svizzera 71
TR - Turchia 68
SG - Singapore 64
RO - Romania 63
BE - Belgio 39
NL - Olanda 38
PL - Polonia 35
AT - Austria 34
UZ - Uzbekistan 24
GR - Grecia 23
EU - Europa 22
LB - Libano 20
CA - Canada 18
MX - Messico 11
CZ - Repubblica Ceca 10
JP - Giappone 9
KR - Corea 8
AU - Australia 4
BR - Brasile 4
RS - Serbia 4
ES - Italia 3
AR - Argentina 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
IL - Israele 2
KZ - Kazakistan 2
LV - Lettonia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
HU - Ungheria 1
IM - Isola di Man 1
IN - India 1
IR - Iran 1
IS - Islanda 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 22.003
Salva come PNG Salva come JPEG
Città #
Chandler 2.394
Dublin 2.100
Jacksonville 1.146
San Mateo 1.146
Hong Kong 704
Dong Ket 648
Medford 536
Princeton 532
Altamura 490
Wilmington 400
Lawrence 388
Perugia 384
Des Moines 364
Andover 343
Ann Arbor 308
Ashburn 196
Beijing 193
Saint Petersburg 147
Boardman 110
Norwalk 97
San Paolo di Civitate 83
Falls Church 78
Woodbridge 76
Redmond 69
Los Angeles 68
Izmir 66
Bucharest 53
Helsinki 47
Dearborn 45
Brussels 38
Shanghai 37
Moscow 33
Redwood City 32
Rome 31
Den Haag 29
Milan 29
Singapore 29
Lausanne 17
Houston 16
Frankfurt Am Main 14
Tappahannock 13
Auburn Hills 12
Bologna 12
Edinburgh 12
New York 11
Florence 10
Modena 9
Ottawa 9
Fairfield 8
San Diego 8
Laion 7
Seattle 7
Washington 7
Chicago 6
Fremont 6
Philadelphia 6
Terni 6
Tokyo 6
Frankfurt am Main 5
Genoa 5
Parma 5
Saint Louis 5
Seoul 5
Zhengzhou 5
Carlentini 4
Cava de' Tirreni 4
Foligno 4
Genova 4
Kiev 4
Lucca 4
Nagold 4
Noceto 4
Pomezia 4
Trento 4
Utrecht 4
Verona 4
Amsterdam 3
Baltimore 3
Cambridge 3
Cosenza 3
El Paso 3
Falkenstein 3
Hanover 3
Hefei 3
Jesi 3
Montréal 3
Nanning 3
Napoli 3
Paris 3
Prato 3
Saronno 3
Simi Valley 3
Timisoara 3
Toronto 3
Turin 3
Abidjan 2
Arlandastad 2
Bagnara Calabra 2
Bolzano 2
Brescia 2
Totale 13.816
Salva come PNG Salva come JPEG
Nome #
The validation of an Italian version of the Freezing of Gait Questionnaire 342
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 141
CSF and blood biomarkers for Parkinson's disease 111
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 101
Cyclic vomiting syndrome, migraine, and epilepsy: a common underlying disorder? 91
Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis 87
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 87
Early detection of substantia nigra changes in Parkinson's disease: a magnetization transfer ratio (MTR) study 86
A critical role of NO/cGMP/PKG dependent pathway in hippocampalpost-ischemic LTP: modulation by zonisamide. 86
Deficits of glutamate transmission in the striatum of experimental hemiballism. 85
Phyto-oestrogens in the prophylaxis of menstrual migraine. 82
Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism. 81
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 81
Long-term potentiation and memory processes in the psychological works of Sigmund Freud and in the formation of neuropsychiatric symptoms. 80
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease. 80
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. 79
An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease. 79
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 79
Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression 77
Calcium signaling and neuronal vulnerability to ischemia in the striatum. 77
Skin biopsy: a new diagnostic tool for autonomic dysfunctions in Parkinson's disease? 77
Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation. 76
Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs. 75
Aortic stiffness and pulse wave reflection in young subjects with migraine: A case-control study. 75
Cell-type specificity of mGluR activation in striatal neuronal subtypes. 74
Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity? 74
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 73
Plasticity and repair in the post-ischemic brain 72
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 72
Medication-overuse headache: similarities with drug addiction. 72
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects. 71
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 71
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice. 70
Coordinate high-frequency pattern of stimulation and calcium levels control the induction of LTP in striatal cholinergic interneurons. 70
Modulation of gene expression following long-term synaptic depression in the striatum. 70
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. 70
Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: An immunohistological study. 70
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 68
Pathological Synaptic Plasticity in the Striatum: Implications for Parkinson's Disease. 67
Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease 67
L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases. 67
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum. 67
Cerebrospinal fluid biomarkers in Parkinson disease. 67
Ischemic bilateral hippocampal dysfunction during transient global amnesia. 66
Acute dystonia induced by the combination of midodrine and perphenazine. 66
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 66
Removing Pathogenic Memories: A Neurobiology of Psychotherapy. 65
Basi neurobiologiche dei deficit cognitivi nella malattia di Parkinson 65
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. 64
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. 64
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices. 64
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. 64
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. 64
Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. 63
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 63
Association between migraine and headache attributed to stroke: a case-control study. 62
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 62
Functional interactions within striatal microcircuit in animal models of Huntington's disease. 62
Pharmacological inhibition of the Na(+)/Ca(2+) exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory amino acids in rat striatal neurons. 61
Application of the ICHD-II criteria to the diagnosis of primary chronic headaches via a computerized structured record. 61
c-Jun N-terminal Kinase regulates soluble Abeta oligomers and cognitive impairment in an AD mouse model. 61
Clinical aspects and management of levodopa-induced dyskinesia. 61
A possible mechanism for the aglycemia-induced depression of glutamatergic excitation in the striatum. 61
Diagnostic accuracy of Parkinson disease by Support Vector Machine (SVM) analysis of 123I-FP-CIT brain SPECT data: implications of putaminal findings and age 61
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 61
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 61
Hippocampal epileptogenesis in autoimmune encephalitis 61
Adrenomyeloneuropathy partially responsive to steroid pulse therapy. 60
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 60
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 60
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. 59
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 59
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 59
Effects of glycine on neurons in the rat substantia nigra zona compacta: in vitro electrophysiological study. 59
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway. 59
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 59
Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease. 58
Involvement of intracellular calcium stores during oxygen/glucose deprivation in striatal large aspiny interneurons. 58
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication. 58
Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP. 58
Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's disease. 58
Occipital arteriovenous malformations andmigraine. 58
Acetylcholine-mediated modulation of striatal function. 57
The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area. 57
Basic research in substantia nigra and ventral tegmental area: clinical implications. 57
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 57
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 57
Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons. 57
Endogenous Ach enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation 56
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 56
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia. 56
Basal ganglia disorders. An electrophysiologic approach. 56
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra. 56
Visual pathway involvement in multiple sclerosis: Look straight in the eyes 56
Application of ICHD 2nd edition criteria for primary headaches with the aid of a computerised, structured medical record for the specialist. 56
Adenosine-mediated inhibition of striatal GABAergic synaptic transmission during in vitro ischaemia. 55
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. 55
Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission. 55
The modulation of dopamine receptors in rat striatum. 55
Electrophysiological effects of amineptine on neurones of the rat substantia nigra pars compacta: evidence for an inhibition of the dopamine uptake system. 55
Totale 7.047
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.615
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019110 0 0 0 0 0 0 0 0 0 0 103 7
2019/20202.233 105 36 345 21 333 83 358 82 368 208 46 248
2020/20214.643 23 335 176 336 1.366 263 293 73 535 153 370 720
2021/20224.441 88 792 110 257 135 55 55 1.426 88 162 475 798
2022/20237.812 619 1.433 157 640 587 979 10 314 2.708 20 258 87
2023/20241.890 166 310 154 59 31 18 433 134 361 92 132 0
Totale 23.112